Brochures Overview
Covalent drugs pose unique challenges, including complex pharmacokinetics, diverse metabolism, and off-target toxicity, requiring specialized expertise. At WuXi AppTec DMPK, we leverage extensive experience in bioanalysis, in vitro ADME, metabolite identification, and radiolabeled ADME to address these challenges. Our tailored research platforms and integrated pharmacokinetic strategies ensure reliable data and support for successful preclinical development.
Complete the form to view and download this brochure.
Stay Connected
Keep up with the latest news and insights.